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Abstract.  The cartilage matrix deficiency (cmd/cmd) 
mouse fails to synthesize the core protein of cartilage- 
characteristic proteoglycan (cartilage PG).  Chondro- 
cytes from the cmd/cmd cartilage cultured in vitro 
produced nodules with greatly reduced extracellular 
matrix.  Immunofluorescence staining  revealed that the 
nodules of mutant cells differed from the normal in 
lacking cartilage PG and in uneven and reduced depo- 
sition of type II collagen.  Exogenously added cartilage 
PG prepared from either normal mouse cartilage or 
Swarm rat chondrosarcoma to the culture medium was 
incorporated exclusively into the extracellular ma- 
trices of the nodules, with a concurrent correction of 
the abnormal distribution pattern of type II collagen. 
The incorporation of cartilage PG into the matrix was 
disturbed by hyaluronic acid or decasaccharide derived 
therefrom,  suggesting that the incorporation process 
involves the interaction of added proteoglycan with 
hyaluronic acid.  Both the hyaluronic acid-binding  re- 
gion and the protein-enriched  core molecule prepared 
from rat chondrosarcoma cartilage PG could also be 
incorporated but, unlike the intact cartilage PG, they 
were distributed equally in the surrounding  zones 
where fibroblast-like cells predominate.  The results in- 
dicate that the intact form of cartilage PG is required 
for specific incorporation into the chondrocyte nod- 
ules, and further  suggest that cartilage PG plays a 
regulatory role in the assembly of the matrix macro- 
molecules. 
T 
HE extracellular  matrix  of cartilage  is composed pri- 
marily of cartilage-characteristic  proteoglycan  (carti- 
lage PG) t and type II collagen.  Cartilage  PG is pres- 
ent in the matrix  as high  molecular weight  aggregates  in 
which proteoglycan monomers bind specifically to hyaluron- 
ic acid at regular intervals through  stabilization by link pro- 
tein (8).  Type II collagen  molecules also are assembled to 
form fibrils with characteristic  size and morphology (for re- 
view, see reference 33). 
Cartilage  matrix  deficiency  (cmd/cmd)  is  an  autosomal 
recessive lethal mutation in mice resulting in a syndrome in- 
cluding  disproportionate  dwarfism,  short  snout,  and cleft 
palate (26).  These abnormalities  have been shown to result 
from failure in the synthesis of cartilage PG core protein (15). 
Other matrix components,  such as type II collagen,  small 
proteoglycans,  hyaluronic acid, and link protein are synthe- 
sized nearly at normal rates  (3,  15,  18). Therefore,  the cell 
culture of cmd/cmd chondrocytes provides a useful system 
in which the function in matrix assembly of cartilage PG may 
be studied. 
1. Abbreviations  used in this paper:  cartilage PG, cartilage-characteristic 
proteoglycan; PG-H, cartilage PG from 12-d-old chick embryo epiphyseal 
cartilage. 
We show here that  cmd/cmd chondrocytes in monolayer 
culture exhibit an abnormal extracellular  matrix and that the 
abnormality could be corrected by adding cartilage PG to the 
culture medium. Evidence is presented to show that the ex- 
ogenous cartilage  PG is integrated into the matrix of mutant 
chondrocytes through the processes in which the interactions 
of an  intact  form  of cartilage  PG with  the  other  matrix 
molecules are involved. 
Materials and Methods 
Materials 
Crude collagenase CLS III and fetal calf serum were purchased from Gibco, 
Grand Island,  NY;  testicular  hyaluronidase  (grade V)  was  from Sigma 
Chemical Co.,  St. Louis, MO.; Dulbecco's modified Eagle's medium and 
Hanks' basal salt solution were from Nissui,  Tokyo,  Japan;  Dispase was 
from Godo Shusei, Tokyo, Japan; culture dishes were from Falcon Labware, 
Becton, Dickinson &  Co.,  Oxnard, CA; nonfluorescence coverslips were 
from Matsunami Glass,  Ohsaka, Japan;  and [3~S]sulfate  was from Japan 
Radioisotope Association, Tokyo, Japan. Rat chondrosarcoma cartilage PG, 
the clostripain produced hyaluronic acid-binding region, the chondroitin 
sulfate-rich region (4), the chondroitinase ABC-produced protein-enriched 
core molecule (24) derived therefrom, and cartilage laG from 12-d-old chick 
embryo epiphyseal cartilage (PG-H) (14) were prepared as described as pre- 
viously. Fluorescein isothiocyanate-conjugated goat anti-rabbit IgG, fluo- 
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rhodamine  isothiocyanale-conjugated rabbit  anti-guinea  pig  IgG,  and 
nonimmnnized goat  serum  were  obtained  from  Cappel  Laboratories, 
Cochranville, PA. Antibodies to rat chondrosarcoma cartilage PG fraction 
(aAI-DI) raised in a rabbit (15) were given by Dr. H.-J. Barrach (National 
Institute of Dental Research, National Institutes of Health, Bethesda, MD). 
Their specificity was established by the enzyme-linked immunosorbent as- 
say (25) and the immanoltnorescence labeling of target tissues (15, 16, 18). 
The antiserum had a titer 0f  >12,000 against the injected antigen and showed 
little  activity  (titer,  <50  by  the  enzyme-linked immunosorbent  assay) 
against type II collagen, fibronectin, link protein, and small proteoglycans 
from the normal rat cartilage. The hyahronic acid-binding region and the 
chondroitin sulfate-rich region prepared from cartilage PG were recogniz- 
able with the antiserum, but their antigenic activities were about one-tenth 
and one-fitLieth, respectively, the activity of the intact proteoglycan, as mea- 
sured by the ergyrne-linked immunosorbeut assay. The guinea pig antibod- 
ies to rat chondrosarcoma type II collagen were a gift from Dr. J.-M. Foidart 
(National Institute of Dental Research, NIH). The antiserum was purified 
by crossimmunoadsorption and its specificity was established elsewhere (5, 
16). The rabbit antibodies la rat chondrosarcoma link protein (31) and the 
rabbit antibodies to mouse Englebreth-Holm-Swarm tumor proteoheparan 
sulfate (9) were kindly given by Dr. J. H. Kimura (Rush-Presbyterian-St. 
Luke's Medical Center, Chicago, IL) and Drs. J. Hassell and G. R. Martin 
(National Institute of Denial Research, NIH), respectively. The rabbit anti- 
bodies to  PG-H  were prepared as described previously  (15) and their 
specificity was established elsewhere (28). Hyaluronic acid and its oligosac- 
charide derivatives were given by Mr. M. Mizutani, Seikagaku Kogyo Co., 
Tokyo, Japan. 
Chondrocyte Culture 
18- or D-d-old embryos were obtained from proven cmd/+  x  cmd/+ mat- 
ings and separated into normal and cmd/cmd by their characteristic features. 
The epiphyseal cartilages of the embryonic knee joints were dissected free 
of the muscle and the ossified shaft in Hanks' basal salt solution containing 
5% fetal calf serum. The cartilages were suspended in Dispase (400 U/mi) 
in Hanks' basal salt solution containing 5 % fetal calf serum and incubated 
at 37°C for 30 min with gentle stirring. The perichondral layers and connec- 
tive tissues surrounding the cartilages were removed by this treatment. 
Chondrocytes were then dissociated by incubating the cartilaginous tissues 
for 2 h in 0.1% (wt/vol) collagenase solution in Dulbecco's modified Eagle's 
medium containing 10% fetal calf serum as described by Benya et al. (1). 
After gentle pipetting, dissociated cells were passed through a Nitex filter 
(20-~tm  pore size) to remove aggregating cells and resuspended in Dul- 
becco's modified Eagle's medium containing 10%  fetal calf serum, 50  U 
penicillin/ml, and 50  ~g strep~mycin/nfi (medium A).  About  105 cells 
were seeded into a 35-mm Falcon tissue culture dish containing 2 ml of 
medium A, or on a sterilized coverslip in the same dish. Incubation was car- 
ried out at 37°C in a humidified atmosphere of 95 % air/5 % CO2. Medium 
was  changed  every  other  day.  Where  indicated,  the  media  were  sup- 
plemented, on the second day of culture, with mouse cartilage PG (5,  10, 
or 50 ~g/ml), mouse proteoheparan sulfate (10 ~g/ml), rat chondrosareoma 
cartilage PG (10 Bg/ml), or chick PG-H (50 ~tg/mi). In experiments where 
inhibition of the incorporation of cartilage PG into the cmd/cmd matrix was 
to be examined, hyaluronic acid (50 ~tg/mi), oligosaccharide from hyaluron- 
ic acid (50 Isg/ml), or chondroitin sulfate (50 p.g/ml) was added simultane- 
ously with the cartilage PG. When structural specificity of the proteoglycan 
for the incorporation ability was to be examined, the hyaluronic acid-bind- 
ing region (10 I.tg/mi), the chondroitin sulfate-rich region (10 I~g/ml), or the 
protein-enriched core molecule (10 ~tg/ml), prepared from rat chondrosar- 
coma cartilage PG was added to the cmd/cmd chondrocyte cultures. 
Preparation of Cartilage PG 
Epiphyseal cartilages were dissected from 18-d-old normal mouse embryos. 
The cartilages were extracted twice with 4 M guanidine-HCl in 0.2 M Tris- 
HCI, (pH 8.0), containing protease inhibitors (0.01 M EDTA, 0.01 M N-eth- 
ylmaleimide,  1 mM phenylmethanesulfouylfluoride, and 0.36  mM pep- 
statin) at 4°C for 24 h as previously described (14, 23). The extracts were 
centrifuged at 10,000 rpm for 20 min at 4°C. The supernatant solution was 
dialyzed against 9 vol 0.2 M Tris-HCl (pH 8.0) containing the protease in- 
hibitors. The solution was then subjected to CsCI isopycnic centrifugation 
under the associative condition with a starting density of 1.62 g/ml (6), in 
a rotor (model RP55T; Hitachi, Tokyo) at 40,000 rpm at 10°C for 50 h. The 
bottom third of  the gradient (A1) was collected (6). The A1 fraction was sub- 
jected to CsCI isopycnic centrifugation under the dissociative condition in 
4 M guanidine-HCI containing the ~  inhibitors with a starting density 
of 1.45 g/mi as described above. The bottom third of the gradient, (A1-DI), 
was collected (10), dialyzed for 24 h against two l-l changes of 0.01 M Tris- 
HCl (pH 7.5) and finally against distilled water for 12 h. The dialyzed solu- 
tion was lyophilized, weighed, and redissolved in a small volume of the cul- 
ture medium. Using the procedure of Bitter and Muir (2), the amount of 
proteoglycan in solution was estimated by measuring hexuronate that ac- 
counts for •25%  of the total  weight of the proteoglyean (17). 
Preparation of l~sS]Sulfate-labeled Cartilage-PC, 
Epiphyseal cartilages from 18-d-old normal embryos were preincubated in 
Dulbecco's modified Eagle's medium for 1 h. The medium was then changed 
to 5 ml of Ham's F12 medium containing 500 ttCi of carrier-free [35S]sul- 
fate and 10% fetal calf serum. Incubation was carried out for 24 h at 37°C 
in a humidified atmosphere of 95 % air/5 % COe. Labeled cartilage PG was 
prepared by the same procedure as used for the preparation of unlabeled 
cartilage PG (see above). 
Binding Experiments  of  Radiolabeled Cartilage  laG 
35S-labeled cartilage PG dissolved in medium A was added on the second 
day of culture to the medium of either cmd/cmd or normal chondrocyte col- 
ture at the concentrations indicated in the individual experiments. Where 
indicated, hyaluronic acid (50 ~tg/mi), hyaluronic acid oligosaccharide (50 
~tg/ml), unlabeled rat chondrosarcoma cartilage laG (20 ~tg/ml), the byal- 
uronie acid-binding region (10 ~tg/ml), or the chondroitin sulfate-rich re- 
gion (10 ~tg/mi) was added to the culture media. Incubation was carried out 
at 37°C for 24 h in a humidified atmosphere of 95% air/5% CO2. After a 
24-h incubation, the medium was collected and the cells were washed eight 
times with medium A, similar to the washings in the immunofluorescence 
staining (see below). The spent medium and the washings were combined 
and used as "medium fraction" for determining the amount of 3~S-labeled 
cartilage PG. The cartilage PG incorporated into the cell layer was treated 
with 0.2 M NaOH for 24 h at 37°C to release aSS-labeled glycosaminogly- 
cans. Radioactivity of the released glycosaminoglycans was measured and 
is taken to represent the quantity of 35S-labeled cartilage PG in the cell 
layer fraction. 
Labeling of Cultured Chondrocytes with psS]Sulfate 
for Analyses of  Proteoglycan Synthesis 
On the seventh day of culture, when chondrocytes yielded significant num- 
bers of nodules, medium A containing 20 txCi of [3~S]sulfate/ml was added 
and incubation was continued for 24 h. The spent medium was collected 
for analysis of proteoglycans. Proteoglycans in the cell layer were extracted 
with 4 M guanidine-HC1 containing the protease inhibitors (see above). Un- 
labeled rat chondrosarcoma cartilage laG (200 txg as hexuronate) was added 
as a  carrier to each sample of the media and cell extracts, and macro- 
molecules were recovered by precipitation with ethanol containing 1.3 % 
(wt/vol) potassium acetate. The precipitates were dissolved in water, and the 
precipitation was repeated five times to ensure complete removal of radioac- 
tive low-molecular-weight compounds (13). The macromolecular fractions 
were dissolved in 1 ml of  4 M guanidine-HCl containing the protease inhibi- 
tors and layered on 13 ml of a linear gradient of glycerol (10-35 %, wt/vol) 
in 4 M guanidine-HCl containing the protease inhibitors. The gradient was 
formed on a cushion of 0.5 ml of 50% glycerol in the same solvent (12-14). 
The gradient was centrifuged in a Hitachi RPS25-2 rotor at 22,500 rpm at 
19°C for 28 h (12-14), and then fractionated into 0.6-mi portions. Aliquots 
of each fraction were assayed for radioactive proteoglycans. 
Immunofluorescence Staining 
Chondrocytes cultured on coverslips were rinsed with three changes of PBS 
(pH 7.0) and air-dried. In control experiments to see effects of air-drying 
fixation, samples were directly stained with antibodies without air-drying. 
In some experiments, the cell layers were subsequently treated with bovine 
testicular hyaluronidase (grade V; Sigma Chemical Co.) in PBS (0.2 mg/ml) 
for 15 rain at 37°C and then rinsed three times. For the staining of cartilage 
PG or type II collagen, the samples were incubated in a  humidified at- 
mosphere for 30 min at room temperature with rabbit antibodies to cartilage 
PG or guinea pig antibodies to type II collagen (1:30 dilution). After rinsing 
with five changes of PBS, the treated samples were incubated in a humidi- 
fied atmosphere with fluorescein isothiocyanate-conjugated anti-rabbit or 
guinea pig IgG 0:30 dilution) for another 30 min at roomtemperature. After 
washing with three changes of PBS followed by air-drying, the samples were 
The Journal  of  Cell  Biology,  Volume 103,  1986  1606 Figure L  Morphological features and immunofluorescence staining patterns of day 7  cultures of normal chondrocytes (left) and mutant 
chondrocytes (right). (a and b) Phase-contrast micrographs of the cultures. The extracellular matrix is more abundant in the normal chon- 
drocyte nodules (arrow in a) than in the mutant chondrocyte nodules (arrow in b). (c and d) Immunofluorescence staining of the cultures 
with antibodies to cartilage PG, (e and f) with antibodies to type II collagen, and (g and h) with antibodies to link protein. Bar,  100 ~tm. 
mounted in buffered 90% (vol/vol) glycerol.  Immunofluorescence staining 
with antibodies to link protein, proteoheparan sulfate, or chick PG-H were 
done as described above. 
Double staining of cartilage PG and type II collagen was performed as 
follows. Samples  were subjected  to sequential  treatments with rabbit anti- 
bodies to cartilage PG (1:30 dilution unless otherwise indicated;  30 min; 
room temperature; rinsed with PBS five times), with tetrarnethylrhodamine 
isothiocyanate-conjugated  goat anti-rabbit  IgG (1:30 dilution; 30 min; room 
temperature; rinsed in PBS three times), with guinea pig antibodies to type 
II collagen  (1:30 dilution; 30 rain; room temperature; rinsed in PBS five 
times), and with fluorescein  isothiocyanate-conjugated  rabbit anti-guinea 
pig IgG (1:30 dilution; in the presence of nonimmunized goat serum,  1:2 
Takeda et al. cmd/cmd Chondrocytes in Culture  1607 dilution; 30 min; room  temperature;  rinsed in PBS three  times). Some  sam- 
ples were pretreated with testicular hyaluronidase (see above)  to degrade 
glycosaminoglycans which otherwise might mask the antigens. Fluores- 
cence was observed  under an Olympus  fluorescence  microscope  BHK-II. 
Results 
Comparison of  Chondrocyte Phenotypes in Culture 
Application  of the  cell  dissociation  methods  with trypsin 
resulted in a low viability of mutant chondrocytes. Using col- 
lagenase in the presence of 10% fetal calf serum for the dis- 
sociation of chondrocytes (1) greatly improved the yield as 
well as the viability of the dissociated cells (90% cells were 
viable).  Both  normal  and  mutant  chondrocytes  formed 
monolayers (Fig. 1, a and b). Their growth rates were almost 
similar and nodular assembly of cells was equally recognized 
on day 4  after plating.  But the nodules formed by mutant 
chondrocytes were much smaller in the average volume of 
extracellular matrix than those by normal chondrocytes (Fig. 
1, a  and b). 
Immunofluorescence staining of day 7 cultures with anti- 
bodies to cartilage PG and type II collagen indicated that in 
normal culture both cartilage PG and type II collagen local- 
ized exclusively in the nodules of normal cultures (Fig.  1, c 
and e), whereas cartilage PG was completely absent in those 
of mutant cultures while type II collagen was present (Fig. 
1, d  and f).  These results are consistent with the previous 
observation (15) that mutant cartilages in vivo are defective 
in  cartilage PG synthesis but have an ability to synthesize 
type II collagen. 
It  is  noteworthy  that  the  intensity  of type  II collagen 
fluorescence was lower and the distribution of the fluores- 
cence was much more uneven in the mutant nodules than in 
the normal (Fig. 1, e and  f). Immunohistochemical detection 
of type II collagen in tissue sections of normal cartilage usu- 
ally requires pretreatment of the sections with hyaluronidase 
to eliminate masking substances (for an example, see refer- 
ence 15). However, the intensity of type II collagen fluores- 
cence on both cultures of mutant and normal chondrocytes 
was not augmented by hyaluronidase pretreatment (data not 
shown). Staining with antibodies to type II collagen of both 
samples  prepared  without  air-drying  also  gave the  same 
fluorescence patterns (data not shown). The results rule out 
the possibility that the observed differences in staining pat- 
tern  are due  to  a  denaturation  of the  antigenic  molecules 
caused by air-drying in the absence of cartilage PG. 
In contrast to the apparent differences in the distributions 
of cartilage PG and type II collagen between normal and mu- 
tant cultures as described above, the patterns of link protein 
were almost similar. The fluorescence appears predominant- 
ly in cell surfaces and extraceUular matrices of the nodules 
while weak but significant fluorescence was found in those 
surrounding the nodules (Fig. 1, g and h). Pretreatment with 
hyaluronidase gave no difference in the distribution between 
normal and mutant cultures,  but dramatically reduced the 
staining (data not shown). This suggests that link proteins are 
bound to hyaluronidase-sensitive materials in both cultures. 
Incorporation of  Exogenously Added Cartilage PG into 
Nodules Formed by Mutant Chondrocytes 
Mutant chondrocytes were provided with cartilage PG on day 
2,  by  simply  adding  to  the  culture  medium.  Subsequent 
staining  of the  cultures  with  antibodies  to  cartilage  PG 
demonstrated that the molecule was more incorporated into 
the extracellular matrices of the nodules as the formation of 
the nodules progressed and as the concentration increased 
(Figs. 2 and 3).  Continuous culturing until day 7 when the 
complete nodules were constructed and the addition of 10 ~tg 
dry  weight of cartilage  PG/ml yielded  maximum fluores- 
cence.  A  phase-contrast micrograph (cf.  Fig.  6  i)  clearly 
shows that the addition of cartilage PG increased the volume 
of extraceUular matrix in nodules of mutant cultures to the 
level  seen  in  normal  cultures.  In  contrast,  no  apparent 
change in the nodular structure was observed when normal 
chondrocytes were cultured in the presence of cartilage PG 
(data not shown). 
It is possible that the addition of cartilage PG caused in- 
duction of cartilage PG biosynthesis or remodeled proteogly- 
cans in mutant chondrocytes. To investigate this possibility, 
normal and mutant chondrocyte cultures on day 7 were meta- 
bolically labeled with [35S]sulfate with or without addition 
Figure 2. Time course of the incorporation of exogenously added mouse cartilage PG into the mutant chondrocyte culture. Mutant chondro- 
cytes were cultured for 24 h (a), 48 h (b), 96 h (c), and 144 h (d) in the presence of 10 ~tg of normal mouse cartilage PG/ml. Progressive 
increase of the fluorescence of cartilage PG with time is apparent.  Bar, 100 I.tm. 
The Journal of Cell Biology, Volume 103, 1986  1608 Figure 3.  Incorporation of cartilage PG into the extracellular matrix of mutant chondrocytes as a function of the concentration of added 
cartilage PG. The cells were cultured in the absence (a) or presence of 5 gg (b),  10 ~tg (c), or 50 gg (d) of cartilage PG/ml. After 6 d 
of incubation, the cultures were stained with antibodies to cartilage PG. The highest intensity of fluorescence is apparent in (c). Bar,  100 p.m. 
of cartilage PG.  The cell layers and spent media were ana-  -~ 
lyzed for 35S-labeled proteoglycans by glycerol density gra- 
dient centrifugation (Fig. 4). Both the cell layer and medium  ~-  3 
from  the  normal  showed  a  typical  bimodal  sedimentation  o 
profile of 35S-labeled proteoglycans  of cartilaginous  tissues  x 
(15).  Compared with the normal,  all samples from the mu-  E  O.  o  2  tant  lacked  the  faster  sedimenting  35S-labeled  component 
that corresponds to cartilage PG (fractions 6-17).  Both nor-  > 
mal  and  mutant  cultures  synthesized  and  secreted  slower 
sedimenting proteoglycans. This may represent proteoglycan  .o_  ! 
species  distinct  from  cartilage  PG  in  cartilage  (so-called  "~  ¢0 
tr 
small  proteoglycans),  although  their  sedimentation  rates  05 
were slightly faster in the mutant than in the normal. A simi- 
lar difference in the sedimentation  rates of small proteogly- 
cans has also been observed with normal and cmd/cmd car- 
tilages  in  vivo  (15).  The  addition  of cartilage  PG  to  the 
medium had no effect on the synthesis and secretion of the 
slower sedimenting  proteoglycans.  Thus,  the appearance of 
the cartilage PG fluorescence in the mutant nodules resulted  .r. 
from the  incorporation  of added  exogenous  cartilage  PG. 
O 
Response of  Mutant Nodules to Exogenously Added  x  E 
Cartilage PG  ~  10 
v 
To  investigate  whether  added  exogenously  added  cartilage  .~ 
> 
PG effects the distribution  of type II collagen,  antibodies to 
these  molecules  were  used  in  double  immunofluorescence  _~  5 
reaction. The cartilage PG and type II collagen fluorescence  v 
rr  had similar localization in nodules of normal day 7 cultures  05 
(Fig. 5, a and b). In contrast, the nodules of mutant chondro- 
cyte cultures without the addition of cartilage PG completely  0 
lacked the cartilage PG fluorescence and showed only a weak 
and  unevenly  distributed  fluorescence  of type  II collagen 
(Fig.  5,  d  and  e).  However,  the  nodules  of mutant  culture 
formed  with  the  addition  of exogenous  cartilage  PG  were 
similar to the normal in both intensity and distribution  pat- 
tern  of the  cartilage  PG  and  type  II collagen  fluorescence 
(Fig.  5, g and h).  Moreover, the addition of cartilage PG in- 
creased  the  volume  of extracellular  matrix  in  the  nodules 
nearly  to the  normal  level  (Fig.  5  i). 
5  10  20  25 
Fraction  number  (O.6ml/tube) 
-  -  -  •  J  r 
5  10  15  20  25 
Fraction  number  (0.6ml/tube) 
Figure 4.  Zone sedimentation profiles of [35S]sulfate-labeled  pro- 
teoglycans in the cell layers (a) and the media (b) obtained from 
normal chondrocyte culture (e) and from mutant chondrocyte cul- 
tures in the absence (0) or presence of 10 gg of cartilage-PG/ml 
(zx). Zone sedimentation of the labeled proteoglycans were carried 
out as described in Materials and Methods.  After the centrifuga- 
tion, tubes were fractionated from the bottom to the top. 
"Pakeda  et  al.  cmd/cmd Chondrocytes  in  Culture  1609 Figure 5.  Double immunofluorescence staining  of day 7 cultures of normal chondrocytes (a and b), and of mutant chondrocytes grown 
in the absence (d and e) or presence of 10 pg of cartilage PG/ml (g and h). The cultures were stained simultaneously with rabbit antibodies 
to cartilage PG (a, d, and g) and guinea pig antibodies to type II collagen (b, e, and h). Phase-contrast micrographs of (a and b), (d and 
e), and (g and h) are shown in c, f,  and i, respectively. Bar,  100 pm. 
Inhibition of  Cartffage PG Incorporation into 
Mutant Chondrocyte Nodules by Hyaluronic Acid and 
Oligosaccharides Derived Therefrom 
It is known that hyaluronic acid otigosaccharides or polysac- 
charides  consisting  of five or more disaccharide  repeating 
units bind effectively to cartilage PG, thereby competitively 
inhibiting  the  interaction  of cartilage  PG  with  hyaluronic 
acid of a high molecular weight (7,  19).  Simultaneous addi- 
tion of hyaluronic acid of high molecular weight (Mr "~8  x 
105)  or  hyaluronic  acid  decasaccharide  caused  a  marked 
reduction  in the incorporation rate of cartilage PG into mu- 
tant nodules  (Fig.  6,  a  and c) with concurrent  reduction  in 
the deposition of type II collagen (Fig.  6, b  and d).  In con- 
trast, neither hyaluronic acid octasaccharide nor chondroitin 
sulfate had  such  effects (Fig.  6, e-h). It appears likely that 
the interaction of added exogenous cartilage PG with endog- 
enous hyaluronic acid is at least necessary for the incorpora- 
tion and the correction  of the type II collagen distribution. 
Structural Specificity of  Cartilage PG  for the 
Incorporation  into Nodules 
Cartilage PG prepared from the Swarm rat chondrosarcoma 
(22)  was incorporated  into the nodules  of mutant  chondro- 
cyte culture as efficiently as mouse cartilage PG (Fig.  7 c). 
The Journal of Cell Biology, Volume 103, 1986  1610 Figure 6.  Effects  of simultaneous addition of hyaluronic acid or 
oligosaccharides  derived therefrom on the localization of cartilage- 
PG and type II collagen in mutant chondrocytes culture. The chon- 
drocytes were cultured in media containing 10 p.g of cartilage-PG 
and 50 lag of hyaluronic acid (a and b), 50 lag of decasaccharide 
(c and d), 50 lag of octasaccharide (e and  f), or 50 p.g of chondroitin 
sulfate (g and h). On day 7, the cultures were stained doubly with 
rabbit antibodies to cartilage PG (a, c, e, and g) and guinea pig anti- 
bodies to type II collagen (b, d, f, and h).  Bar,  100 lam. 
A  resultant correction of the nodules with respect to type II 
collagen distribution pattern was also observed to the same 
extent as seen with cartilage PG from normal mouse carti- 
lage (Fig. 7 d). However, cartilage PG prepared from PG-H 
(14) incorporated less efficiently than mouse cartilage PG, as 
assessed by the low intensity of PG-H fluorescence and the 
incomplete correction of the type II collagen distribution pat- 
tern (Fig. 7, a  and b). Proteoheparan sulfate from the mouse 
Englebreth-Holm-Swarm  tumor  was  neither  incorporated 
Figure 7. Species specificity of cartilage PG and structural require- 
ments for the incorporation into the mutant nodules. Mutant chon- 
drocytes were cultured for 7 d in the presence of PG-H (50 Ilg/ml) 
(a and b), cartilage PG from Swarm rat chondrosarcoma (10 I.tg/ml) 
(c and d), the hyaluronic acid-binding region (10 I.tg/ml) (e and  f), 
the chondroitin sulfate-rich region (10 I~g/ml) (g and h),  or the 
protein-enriched core molecule (I0 I.tg/ml) (i and j) prepared from 
rat chondrosarcoma cartilage PG. Cultures were stained simultane- 
ously with guinea pig antibodies to type II collagen (b, d, f, h, and 
j), and either rabbit antibodies to PG-H (a) or rabbit antibodies to 
rat chondrosarcoma cartilage PG (c, e, g, and i). Bar,  100 lam. 
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mutant chondrocyte culture (data not shown). 2 
The hyaluronic acid-binding region and chondroitin sul- 
fate-rich region prepared from rat chondrosarcoma cartilage 
PG by clostripain digestion (4) were examined for their abil- 
ity to be incorporated into the mutant nodules. The former 
was incorporated into both the nodules and the surrounding 
fibroblastic regions with no significant correction of type II 
collagen distribution pattern (Fig. 7, e and f). The chondroi- 
tin sulfate-rich region, in contrast, was neither incorporated 
into the nodules nor into the surrounding regions, as judged 
by the complete absence of the cartilage PG fluorescence and 
by its failure to correct the type II collagen distribution pat- 
tern (Fig. 7, g and h).  The protein-enriched core molecule 
prepared from rat chondrosarcoma cartilage PG by chon- 
droitinase AC-II digestion (23) was incorporated into both 
the nodules and the surrounding regions as was the hyaluron- 
ic acid-binding region, but the fluorescence showed a pat- 
tern that clots scattered throughout the culture (Fig. 7 i). The 
fluorescence of type II collagen appeared associated with 
clots (Fig. 7 j). Because the protein-enriched core molecules 
have a strong tendency to form aggregates in an aqueous so- 
lution, it is likely that the properties caused a nonspecific ad- 
sorption of type II collagen released into the medium to the 
aggregates or coprecipitation of the type II collagen with the 
aggregates. 
Incorporation of the Radiolabeled  Cartilage PG 
into Mutant Chondrocyte  Culture and the Effects of 
Simultaneous Addition of Various Compounds 
The immunofluorescence data in Figs. 6 and 7 were obtained 
with the long-term cultures where the matrix construction 
appeared to be influenced by many processes, such as degra- 
dation. To see whether the cartilage PG fluorescence was a 
reflection of the incorporation rates of added exogenous car- 
tilage PG or not, the mutant cultures on day 2 were exposed 
for  a  short  time  (24  h)  simultaneously  to  [35S]sulfate- 
labeled mouse cartilage PG and to various compounds hav- 
ing inhibitory effects on the appearance of the cartilage PG 
fluorescence in the mutant nodules. When the labeled carti- 
lage PG was added to a final concentration <10 lag/ml,  ,o1% 
of the  added  35S  was  recovered in  the  mutant  cell  layer, 
whereas 0.3 % or less was in the normal cell layer (data not 
shown).  Because  almost  all  of the  bound  35S  could  be 
released by treatment with chondroitinase ABC, it is likely 
that the labeled molecules were located extracellularly in a 
form bound to the cell surfaces (data not shown). When vari- 
ous compounds were simultaneously added at the same con- 
centrations as those used for the immunofluorescence stain- 
ing studies, the incorporation of 35S-labeled cartilage PG to 
the mutant cell layer was inhibited to '~30% by hyaluronic 
acid, by decasaccharides derived therefrom, by the hyaluron- 
ic acid-binding region of rat chondrosarcoma cartilage PG, 
or less but significantly, by chick PG-H. In contrast, hyal- 
uronic acid octasaccharides, the chondroitin sulfate-rich re- 
gion of rat chondrosarcoma cartilage PG, or chondroitin sul- 
2. Immunofluorescence  staining of normal and mutant chondrocyte  cultures 
revealed the presence of endogenous proteoheparan sulfate in the chondro- 
cyte  nodules.  Although it  was somewhat difficult  to determine  whether 
added proteoheparan sulfate was incorporated into the matrices, lack of in- 
creased fluorescence suggested that added exogenous proteoheparan sulfate 
was not incorporated. 
No  addition (control)' 
+  HA 
+  HAlo 
+  HA8 
+  HABR 
+  CSRR 
+  Ch4S 
+  rat  PG 
+chick PG-H ~ 
,(28%) 
,(32%) 
~(30%) 
,(26%) 
, (46%) 
,(I 00%) 
,(106%) 
~(95%1 
, (102%) 
Figure 8.  Inhibition  by  various  compounds  of the  binding of 
35S-labeled cartilage PG to mutant chondrocytes in monolayer cul- 
ture. The compounds tested are; hyaluronic acid (HA), 50 I.tg/ml; 
hyaluronic acid decasaccharide (HAlo), 50 gg/ml; hyaluronic acid 
octasaccharide (HAs), 50 I.tg/ml; the hyaluronic acid-binding re- 
gion (HABR) from rat chondrosarcoma cartilage PG, 10 ~g/ml; the 
chondroitin sulfate-rich region (CSRR) from rat chondrosarcoma 
cartilage-PG, 10 gg/ml; chondroitin 4-sulfate (Ch4S), 50 gg/ml; 
unlabeled rat chondrosarcoma cartilage PG (rat PG), 20 txg/ml; or 
chick  PG-H,  50  gg/ml.  35S-Labeled mouse  cartilage  PG  (10 
Ixg/ml) was added together with the indicated compounds. Values 
in parenthesis indicate the amounts of radioactivity incorporated to 
the cell layer during a 24-h incubation. The amount of asS-labeled 
mouse cartilage PG incorporation in the absence of inhibitor is 
designated as 100%. 
fate had no such effect (Fig. 8). The results are within those 
expected from the immunofluorescence staining studies. 
Discussion 
Previous biochemical studies on the epiphyseal growth plate 
of cmd/cmd  mouse showed that the  cartilage  synthesized 
type II collagen and link protein nearly at normal rates, but 
that the synthesis of the core protein of cartilage PG was un- 
detectable (15, 18). In present reports, we have shown that 
chondrocytes derived  from  the  mutant  cartilage  also  ex- 
pressed the metabolic error in culture and yielded nodules 
where chondrocytes closely packed in greatly reduced ex- 
tracellular matrix lacking cartilage PG and showing uneven 
and  sparse  distribution of type II collagen.  We have also 
shown that these abnormalities were corrected, i.e., changed 
toward normal, by simply adding to the culture medium car- 
tilage PG isolated from either normal mouse cartilage or 
Swarm rat chondrosarcoma.  3 The results not only indicate 
that  the  abnormalities  of the  mutant  matrix  undoubtedly 
resulted from the deficiency of cartilage PG, but also suggest 
that  in the  absence of cartilage PG,  type II collagen can 
hardly be processed to a mature insoluble form or be ade- 
quately assembled so that a soluble (immature) form of type 
II collagen is largely released into the culture medium. It is 
known that aggregation of the tropocollagen depends upon 
the presence and amount of sulfated glycosaminoglycans or 
proteoglycans (20,  21, 27, 32). The present results have for 
the first time demonstrated that the processing or assembly 
of type II collagen by growing chondrocytes may be influ- 
enced by a failure of the cells to synthesize cartilage PG. 
Sommarin and Heineg~rd (29) showed a time-dependent 
35  and saturable binding of [  S]sulfate-labeled cartilage PG to 
3.  Unlike  normal chondrocytes,  mutant chondrocytes  synthesize  and ac- 
cumulate fibronectin  at a high rate. This abnormality can also be corrected 
by adding  the cartilage  PG to the culture medium (unpublished observa- 
tions). 
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In their study, the added 35S-labeled proteoglycans appeared 
to be integrated as a  part of the pericellular matrix.  The 
results of  our immunofluorescence study and binding experi- 
ments of radiolabeled cartilage PG also suggest that exoge- 
nous cartilage PG was integrated into the matrix of mutant 
chondrocyte nodules. Hyaluronic acid, decasaccharide de- 
rived therefrom, and unlabeled hyaluronic acid-binding re- 
gion,  but not hyaluronate octasaccharide and chondroitin 
sulfate, inhibited the binding as well as the incorporation. 
This  suggests  that  the  interaction  of cartilage  PG  with 
hyaluronic acid via the hyaluronic acid-binding region either 
at the chondrocyte cell surface or in the extracellular matrix 
of chondrocyte nodules is essential for the binding. 
It  is  known  that  the  interaction  of cartilage  PG  with 
hyaluronic acid is essentially irreversible in the presence of 
link protein (6-8).  The added exogenous cartilage PG ap- 
peared to be assembled into stable hyaluronic acid-link pro- 
tein-proteoglycan aggregates  in  the  extracellular  matrix, 
since in our immunofluorescence study and binding experi- 
ment the fluorescence and radioactivity were detected, re- 
spectively, after extensive rinsing in PBS (even using PBS 
containing 1 mg/ml hyaluronic acid, the same results were 
obtained). Kimura et al. (19) observed that, when hyaluronic 
acid of 16 sugar residues, which are long enough to interact 
reversibly with the cartilage PG even in the presence of link 
protein,  were added to chondrosarcoma cell cultures, the 
formation of stable aggregates in the medium is retarded but 
not prevented. In the present study, however,  simultaneous 
addition of cartilage PG and hyaluronic acid decasaccharide 
to the mutant culture medium disturbed the incorporation 
into the extracellular matrix of the nodules (Fig.  6).  The 
difference may be due to the possibility that both the amount 
and length of the decasaccharide were sufficient to displace 
and release endogenous hyaluronic acid from pericellular 
matrix to medium, or the excessive amount of the decasac- 
charide (50 gg/ml) caused the binding of essentially all the 
added proteoglycan to the decasaccharide. 
It is noteworthy that cartilage PG are not incorporated into 
the surrounding fibroblastic cell zones despite the presence 
of both hyaluronic acid and link protein (Fig. 1 h). Both the 
protein-enriched core  molecule and the hyaluronic acid- 
binding region derived from rat chondrosarcoma cartilage 
PG could be deposited in the nodules of mutant chondrocytes 
but, unlike the intact proteoglycan, their deposition was not 
restricted to the chondrocyte nodules but extended to the sur- 
rounding fibroblastic zones. Moreover, they had no ability to 
correct the abnormalities of the mutant chondrocyte nodule. 
These  results  suggest that either  chondroitin sulfate side 
chains or chondroitin sulfate-rich regions of cartilage PG is 
required for both specific incorporation into mutant chon- 
drocyte nodules and correction of the abnormalities of the 
nodules, although free chondroitin sulfate or the chondroitin 
sulfate-rich region alone lacks this ability. Chondroitin sul- 
fate side chains have been shown to be essential for the in- 
teraction between cartilage PG and chondronectin (11). The 
observed  difference between  intact  cartilage  PG  and the 
hyaluronic acid-binding region (or the protein-enriched core 
molecule) derived therefrom suggests the participation in the 
process of cartilage matrix assembly of such a molecule as 
one displaying affinity for chondroitin sulfate. 
Cartilage PG isolated from chick embryo cartilage (PG-H) 
was neither incorporated into the matrix nor corrected the 
abnormalities of mutant chondrocyte nodules as well as the 
mammalian proteoglycans.  PG-H  differs from the  chon- 
drosarcoma cartilage PG in that it contains keratan sulfate 
side chains (22, 23), is rich in high mannose-typed N-linked 
oligosaccharides (30), and has a homologous, but partially 
different, core polypeptide (unpublished observations).  It 
may be that some of these species-specific structural factors 
interfere with proteoglycan-link protein interaction involved 
in the formation of stable proteoglycan aggregates. Alterna- 
tively, species-different environments might expose PG-H 
more to the degradation processes so as to reduce its ability 
to interact with hyaluronic acid. 
We believe that cmd/cmd chondrocyte cultures are well 
suited for determination of the mechanism of matrix assem- 
bly, because the cells yield nodules with a deficient matrix 
that can be modulated by exogenous substances with well 
defined chemical structure. 
We thank Dr. George R. Martin for his continuous encouragement. We are 
also grateful to Dr. Dorothea Bennett for preparing the outcrossed breeding 
stock. M. Takeda and H. lwata are indebted to Professor Takayuki Miura 
for his support. 
This work was supported in part by grants-in-aid for Scientific Research 
and Special Project Research from the Ministry of Education, Science, and 
Culture, Japan. 
Received 6  December 1985,  and in revised form 13 June 1986. 
References 
1. Benya, B. V., S. R. Padilla,  and M. E. Nimni.  1977.  The progeny of 
rabbit  articular chondrocytes synthesize collagen types I  and III  and type I 
trimer, but not type U. Verifications by cyanogen bromide peptide analysis. Bio- 
chemistry.  16:865-872. 
2. Bitter, T., and H. M. Muir. 1962. A modified uronic acid carbazole reac- 
tion. Anal. Biochem.  4:330-334. 
3. Brennan, M. J., A. Oldberg, E. Ruoslahti, K. Brown, and N. Schwartz. 
1983. Immunological  evidence for two distinct chondroitin sulfate proteoglycan 
core proteins. Dev.  Biol. 98:139-147. 
4. Caputo, C. B., D. K. MacCallum, J. H. Kimura, J. Schrode, and V. C. 
Hascall. 1980. Characterization of fragments produced by clostripain digestion 
of proteoglycans from the Swarm rat chondrosarcoma. Arch.  Biochem.  Bio- 
phys.  204:220-233. 
5. Foidart, J.-M., S. Abe, G. R. Martin, T. M. Zizic, E. V. Barnett, J. L. 
Thonar, and S. I. Katz. 1978. Antibodies to type II collagen in relapsing poly- 
chondritis. N.  Engl. J.  Med. 299:1203-1207. 
6. Hascall, V. C., and D. K. Heineg~rd.  1974. Aggregation  of cartilage pro- 
teoglycans. I. The role of hyaluronic acid.  J.  Biol. Chem. 249:4232-4241. 
7. Hascall, V. C., and D. K. Heineg~d. 1974. Aggregation of cartilage pro- 
teoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic  acid 
interactions. J.  Biol. Chem. 249:4242-4249. 
8.  Hascall, V. C. 1981.  Proteoglycans: structure and function. In Biology 
of Carbohydrates. Vol.  1. V. Ginsburg, and P. Robbins, editors. John Wiley 
& Sons, Inc., New York, N.Y.  1-50. 
9. Hassell, J. R., P. G. Robey, H.-J. Barrach, J. Wilczek, S. I. Rennard, 
and G. R. Martin. 1980. Isolation of a heparan sulfate-containing  proteoglycan 
from basement membrane. Proc.  Natl. Acad. Sci. USA. 77:4494--4498. 
10. Heineg~rd, D. K. 1972.  Extraction, fractionation, and characterization 
of proteoglycans from bovine  tracheal  cartilage.  Biochim. Biophys. Acta. 
285:181-192. 
11. Hewitt, A. T., H. H. Varner, M. H. Silver, and G. R. Martin.  1983. 
The role of chondronectin and cartilage proteoglycan in the attachment of chon- 
drocytes to collagen. In Limb Development and Regeneration. Part B. R. O. 
Kelley, P. F. Goetinck, and J. A. MacCabe, editors. Alan R. Liss, Inc., New 
York. 25-33. 
12. Karasawa, K., K. Kimata, K. Ito, Y. Kato, andS. Suzuki. 1979. Morpho- 
logical and biochemical differentiation  of limb bud cells cultured in chemically 
defined medium. Dev. Biol. 70:287-305. 
13. Kimata, K., M. Okayama, A. Oohira, and S. Suzuki. 1974. Heterogene- 
ity of proteochondroitin sulfate produced by chondrocytes at different stages of 
cytodifferentiation.  J.  Biol. Chem. 249:1649-1653. 
14. Kimata, K., Y. Oike, K. Ito, K. Karasawas, and S. Suzuki. 1978.  The 
occurrence of low buoyant density proteoglycans in embryonic chick cartilage. 
Biochem. Biophys.  Res.  Commun.  85:1431-1439. 
15. Kimata, K., H.-J. Barrach, K. S. Brown, and J. P. Pennypacker. 1981. 
Takeda et al. cmd/cmd  Chondrocytes in Culture  1613 Absence of proteoglycan core protein in cartilage from the cmd/cmd (cartilage 
matrix deficiency)  mouse. J.  Biol. Chem. 256:6961-6968. 
16. Kimata, K., J.-M. Foidart, J. P. Pennypacker, H. K. Kleinman, G. R. 
Martin, and A. T. Hewitt. 1982. Immunofluorescence  localization  of fibronec- 
tin in chondrosarcoma cartilage matrix. Cancer Res. 42:2384-2391. 
17. Kimata, K., J. H. Kimura, E. J.-M. A. Thonar, H.-J. Barrach, S. I. Ren- 
nard, and V. C.  Hascall.  1982.  Swarm rat cbondrosarcoma proteoglycans: 
purification of aggregates by zonal centrifugation of preformed cesium sulfate 
gradients. J.  Biol. Chem. 257:3819-3826. 
18. Kimata, K., M. Takeda, S. Suzuki, L  P. Pennypacker, H.-J. Barrach, 
and K. S. Brown.  1983.  Presence of link protein in cartilage from cmd/cmd 
(cartilage  matrix deficiency)  mice. Arch.  Biochem.  Biophys.  226:506-516. 
19. Kimura, J. H., T. E. Hardingham, V. C. Hascall, and M. Solursh. 1979. 
Biosynthesis  of proteoglycans and their assembly into aggregates in cultures of 
choudrocytes from the Swarm rat chondrosareoma. J. Biol. Chem. 254:2600- 
2609. 
20. Obrink, B. 1973. The influence of glycosaminoglycans  on the formation 
of fibrils from monomeric  tropoeollagen in vitro. Fur. J. Biochem. 33:387--400. 
21. Oegema, T. R., Jr., J.  Laiklaw, V. C. Hascall, and D. D.  Dziewiat- 
kowski. ! 975. The effect of protenglycans  on the formation of fibrils from colla- 
gen solution. Arch.  Biochem.  Biophys.  170:698-709. 
22. Oegema, T. R., V. C. Hascall, and D. D. Dziewiatkowski. 1975. Isola- 
tion and characterization of proteoglycans from the Swarm rat chondrosareoma. 
J.  Biol. Chem. 250:6151-6159. 
23. Oike, Y., K. Kimata, T. Shinomura, K. Nakazawa, andS. Suzuki. 1980. 
Structural  analysis of chick-embryo cartilage proteoglycan by selective degra- 
dation with chondroitin lyases (chondroitinases) and endo-15-D-galactosidase 
(keratanase).  Biochem. J.  191 : 193-207. 
24. Oike, Y., K. Kimata, T. Shinomura, and S. Suzuki. 1982.  A mapping 
technique for probing the structure of protenglycan core molecules. J.  Biol. 
Chem. 257:9751-9758. 
25. Rennard, S. I., K. Kimata, B. Dusemund, H.-J. Barrach, J. Wilczek, 
H. J. Kimura, and V. C. Hascall.  1981. An enzyme-linked immunoassay for 
the cartilage proteoglycan. Arch.  Biochem.  Biophys.  207:399--406. 
26. Rittenhouse, E., L. C. Dunn, J. Cookingham, C. Cala, M. Spiegelman, 
G. B. Dooher, and D. Bennett. 1978. Cartilage matrix deficiency  (cmd): a new 
autosomal recessive lethal  mutation in mouse. J.  Embryol.  Exp. MorphoL 
43:71-84. 
27. Scott, J.  E.,  C.  R. Orford, and E.  W. Hughes. 1981.  Proteoglycan- 
collagen arrangement in developing rat tail tendon. Biochem. J.  195:573-581. 
28. Shinomura, T., K. Kimata, Y. Oike, N. Maeda, S. Yano, and S. Suzuki. 
1984. Appearance of distinct types of proteoglycan in a well defined temporal 
and spatial pattern during early cartilage formation in the chick limb. Dev. Biol. 
103:211-220. 
29. Sommarin, Y., and D.  Heineg/trd.  1983.  Specific  interaction  between 
cartilage proteoglycans and hyaluronic acid at the chondrocyte cell surface. Bio- 
chem. J.  214:777-784. 
30. Takahashi,  N.,  H.  Ishihara,  S.  Tejima,  Y.  Oike,  K.  Kimata,  T. 
Shinomura, and S. Suzuki. 1985. The core molecule from type H proteoglycan. 
Release of mannose-containing  oligosaccharides by digestion with N-oligosac- 
charide glycopeptidase. Biochem. J.  229:561-571. 
31. Thonar, E. J.-M., J.  H. Kimura, V. C.  Hascall, A. R.  Poole.  1982. 
Enzyme-linked immunosorbent assay analyses of the hyaluronate-binding re- 
gion and the link protein of proteoglycan aggregate. J. BioL Chem. 257:14173- 
14180. 
32. Toole, B. P., and P. A. Lowther. 1968. The effects of chondroitin sulfate- 
protein on the formation of collagen fibrils in vitro. Biochem. J.  109:857-866. 
33. Trelstad, R. L., and F. H. Silver.  1981. Matrix assembly. In The Cell 
Biology of Extracellular Matrix. E. D. Hay, editor. Plenum Publishing Corp., 
New York.  179-215. 
The Journal of Cell Biology, Volume  103, 1986  1614 